Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2001

01-04-2001 | Conference Report

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

Authors: Catherine Van Poznak, Andrew D. Seidman, Marcus M. Reidenberg, Mark M. Moasser, Nancy Sklarin, Kimberly Van Zee, Patrick Borgen, Marc Gollub, Doreen Bacotti, T-J Yao, Renny Bloch, Monica Ligueros, Martin Sonenberg, Larry Norton, Clifford Hudis

Published in: Breast Cancer Research and Treatment | Issue 3/2001

Login to get access
Metadata
Title
Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial
Authors
Catherine Van Poznak
Andrew D. Seidman
Marcus M. Reidenberg
Mark M. Moasser
Nancy Sklarin
Kimberly Van Zee
Patrick Borgen
Marc Gollub
Doreen Bacotti
T-J Yao
Renny Bloch
Monica Ligueros
Martin Sonenberg
Larry Norton
Clifford Hudis
Publication date
01-04-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1010686204736

Other articles of this Issue 3/2001

Breast Cancer Research and Treatment 3/2001 Go to the issue

Other Index

Subject Index, Volume 66

Conference Report

Sun Valley Summary

Conference Report

Metallothionein 1F mRNA Expression Correlates with Histological Grade in Breast Carcinoma

Conference Report

Association of NK Cell Dysfunction with Changes in LDH Characteristics of Peripheral Blood Lymphocytes (PBL) in Breast Cancer Patients

Conference Report

Expression of Growth Factors, Growth Factor Receptors and Apoptosis Related Proteins in Invasive Breast Cancer: Relation to Apoptotic Rate

Conference Report

An Assessment of Delays in Obtaining Definitive Breast Cancer Treatment in Southern Italy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits